- Integrated efficacy and safety results from SPIRIT-P1 an SPIRIT-P2, t…
Number of the records: 1  

Integrated efficacy and safety results from SPIRIT-P1 an SPIRIT-P2, two phase 3 trials of ixekizumab for the treatment of psoriatic arthritis

  1. Integrated efficacy and safety results from SPIRIT-P1 an SPIRIT-P2, two phase 3 trials of ixekizumab for the treatment of psoriatic arthritis / Combe B. ... [et al.]. Dermatológia pre prax Roč. 12, č. 3 (2018), s. 147-148
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all